Times have changed, but the need for meaningful addiction recovery has never been stronger.
Traditionally, medication assisted treatment (MAT) for addiction recovery has required frequent face to face intervention. Now that we are living in a modern day pandemic, addiction recovery programs have had to adjust the fundamentals of their programming to keep up with COVID-19 safety precautions. The Medical Board has extended its allowance for doctors to provide telemedicine (at their discretion) in an office based opioid treatment (OBOT) program until 3/31/2022. The use of telemedicine requires real time, audio/visual communication; we do not offer any appointments to be conducted over the phone only.
In an effort to continue providing extraordinary care while offering options and solutions to ensure we do our part to help stop the spread, we have modified our program requirements to include telemedicine when appropriate. Treatment utilizing telemedicine is available for active, established and compliant patients who meet specific criteria. This option is determined through an entire chart review based on the individual’s current status, recent history and ongoing needs related to progression of stability. When required in office, please rest assured knowing your safety is our top priority as we have limited office traffic, reserved longer appointment times, implemented above standard sanitation and cleaning protocols. Please contact our support team via Live Chat or at 937-365-HELP if you have any specific questions regarding the use of telemedicine.
Treatment for alcohol use disorder with naltrexone (The Sinclair Method) may be conducted 100% virtually if you are in the state of Ohio, Indiana or Florida.
If you are seeking MAT treatment for opioid use disorder with Suboxone, face to face visits are required but telemedicine can be used when appropriate.
Please visit the specific Program Page for the type of treatment you are interested in to learn more about how we are incorporating telemedicine into your treatment.
Please click here to read our blog on the general guidelines for current patient telemedicine Suboxone program.